Small molecules like rapamycin, Mitoxantrone (PI3K/mTOR inhibitors), and Erlotinib/Cetuximab (EGFR inhibitors) are thought to activate cellular autophagy and apoptosis in various HCC cell lines [167, 170]. This evidence concerns the gene MTOR and hepatocellular carcinoma.